HIGHLIGHTS
- who: . et al. from the Indian Institute of Science (IISc), India Texas AandM University, United States have published the research: SARS-CoV-2 and extracellular vesicles: An intricate interplay in pathogenesis, diagnosis and treatment, in the Journal: (JOURNAL) of 27/06/2022
- what: The aim of SARSCoV-2 treatment is to suppress the immune_response induced by the virus, reducing the damage to both alveolar and capillary epithelial_cells and allowing the recovery of lung tissue and function.
- future: Despite the use of EVs for therapeutic purposes seems promising further investigations are needed to find . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.